drugset / Trial / NCT05695781
Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to compare the safety and efficacy of BRM421 OS to vehicle for the treatment of the signs and symptoms of dry eye disease.
Timeline
- Start
- 2023-02-27
- Primary completion
- 2023-12-30
- Completion
- 2024-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BRM421 | Unknown | — | Topical |